Bharat Biotech's nasal vax priced at Rs 800 for private markets

Bharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at Rs 800 (excluding GST) for private markets and Rs......

Bharat Biotech has two more Covid vaccines in pipeline

Today, the firm has delivered over four billion doses of vaccines and has over 140 patents under its belt. The company has in its portfolio over 16 vaccines and four bio-therapeutics, including......

WHO accepts Bharat Biotech's expression of interest for Covaxin

In a major boost for Bharat Biotech, the World Health Organisation has accepted its Expression of Interest for COVID-19 vaccine Covaxin and scheduled a pre-submission meeting on June 23, a step......

Brazil suspends Bharat Biotech's Covaxin clinical trials

Brazil has suspended the clinical studies of Bharat Biotech's COVID-19 vaccine, Covaxin following termination of the company's agreement with its partner there, the South American Country's......